APA (7th ed.) Citation

Carbone, F., Djamshidian, A., Seppi, K., & Poewe, W. (2019). Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations. CNS drugs, 33(9), 905-918. https://doi.org/10.1007/s40263-019-00661-z

Chicago Style (17th ed.) Citation

Carbone, Federico, Atbin Djamshidian, Klaus Seppi, and Werner Poewe. "Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations." CNS Drugs 33, no. 9 (2019): 905-918. https://doi.org/10.1007/s40263-019-00661-z.

MLA (9th ed.) Citation

Carbone, Federico, et al. "Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations." CNS Drugs, vol. 33, no. 9, 2019, pp. 905-918, https://doi.org/10.1007/s40263-019-00661-z.